硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 GSTO1 抗体对
试剂盒

人 GSTO1 抗体对

01AB01717

Glutathione S-transferase omega 1 (GSTO1) is a cytosolic enzyme that functions as a glutathione-dependent thiol transferase and dehydroascorbate reductase. It plays a vital role in maintaining cellular redox homeostasis and recycling ascorbate, while also participating in detoxification through S-(phenacyl)glutathione reductase activity. Structurally, GSTO1 features a thioredoxin-like N-terminal domain and a C-terminal domain that determines substrate specificity. It is widely expressed and modulates inflammatory signaling pathways in response to oxidative stress. Clinically, genetic polymorphisms in GSTO1 are linked to an altered risk of neurodegenerative conditions, including Alzheimer’s and Parkinson’s diseases, as well as cardiovascular disease and various cancers, likely due to impaired detoxification and redox regulation.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
GSTO1
基因别名
GSTTLP28
蛋白别名
glutathione S-transferase omega 1; GSTO1
UniProt
P78417
物种
Human

产品详情

靶点名称
GSTO1
蛋白名称
glutathione S-transferase omega 1
蛋白别名
Glutathione S-transferase omega-1; GSTO-1; Glutathione S-transferase omega 1-1; GSTO 1-1; Glutathione-dependent dehydroascorbate reductase; Monomethylarsonic acid reductase; MMA(V) reductase; S-(Phenacyl)glutathione reductase; SPG-R
靶点基因名
GSTO1
基因别名
GSTTLP28
UniProt
P78417
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Glutathione S-transferase omega 1 (GSTO1) is a cytosolic enzyme that functions as a glutathione-dependent thiol transferase and dehydroascorbate reductase. It plays a vital role in maintaining cellular redox homeostasis and recycling ascorbate, while also participating in detoxification through S-(phenacyl)glutathione reductase activity. Structurally, GSTO1 features a thioredoxin-like N-terminal domain and a C-terminal domain that determines substrate specificity. It is widely expressed and modulates inflammatory signaling pathways in response to oxidative stress. Clinically, genetic polymorphisms in GSTO1 are linked to an altered risk of neurodegenerative conditions, including Alzheimer’s and Parkinson’s diseases, as well as cardiovascular disease and various cancers, likely due to impaired detoxification and redox regulation.